Samsung Biologics enters manufacturing deals worth US$ 668 million with European pharma company: Incheon, S. Korea Thursday, November 21, 2024, 11:00 Hrs [IST] Samsung Biologics, ...

METAL SUITS' has been selected as one of the Recommended Games by The MIX and is set to participate in the showcase starting ...

GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), ...

Emory Healthcare has successfully implemented Switchboard, MD's MDAware Inbox Management solution, enhancing communication and operational efficiency for staff and clinicians across four specialty ...

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today announced LUMISIGHTtm ...

About Samsung Biologics Co., Ltd. Samsung Biologics (KRX: 207940.KS) is a fully integrated, end-to-end CDMO service provider, ...

The Oss facility also includes purpose-built automated manufacturing flows, and fully integrated analytical capabilities for ...

The approval follows a €20 million investment in a state-of-the-art 45,000 sqft facility offering GMP-compliant Grade C and Grade D cleanrooms designed specifically for nanomedicine manufacturing. The ...

The aseptic fill and finish stage is critical in biological drug manufacturing. Partnering with experienced CMOs like Mabion ...

Kindeva Drug Delivery, a global CDMO and drug delivery expert, has appointed Prakash Pandian as Chief Information Officer ...

Despite selecting the right, compendial excipients for a balanced formulation, you may encounter obstacles that delay market deadlines. Learn how to streamline the formulation and fill-finish process ...